SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028399
Filing Date
2021-05-17
Accepted
2021-05-17 16:17:05
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lhdx-10q_20210331.htm   iXBRL 10-Q 2557678
2 EX-31.1 lhdx-ex311_11.htm EX-31.1 20987
3 EX-31.2 lhdx-ex312_10.htm EX-31.2 20814
4 EX-32.1 lhdx-ex321_9.htm EX-32.1 9728
5 EX-32.2 lhdx-ex322_8.htm EX-32.2 9775
  Complete submission text file 0001564590-21-028399.txt   9203419

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lhdx-20210331.xsd EX-101.SCH 62365
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lhdx-20210331_cal.xml EX-101.CAL 44662
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lhdx-20210331_def.xml EX-101.DEF 215112
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdx-20210331_lab.xml EX-101.LAB 480579
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdx-20210331_pre.xml EX-101.PRE 392985
11 EXTRACTED XBRL INSTANCE DOCUMENT lhdx-10q_20210331_htm.xml XML 1594969
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39976 | Film No.: 21930896
SIC: 2835 In Vitro & In Vivo Diagnostic Substances